Effector T cells expressed the cognate receptors CCR5 and CXCR3, thus the augmented chemokines release promoted robust infiltration of anti-tumor T cells within melanoma TME, which correlated with a better disease control and survival also in melanoma patients (89, 90). This evidence concerns the gene CXCR3 and melanoma.